Estimating Long-Term Survival in the Face of Immature Data- A Case Study of Nivolumab in Second Line Renal Cell Carcinoma
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.066
https://www.valueinhealthjournal.com/article/S1098-3015(17)30400-X/fulltext
Title :
Estimating Long-Term Survival in the Face of Immature Data- A Case Study of Nivolumab in Second Line Renal Cell Carcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30400-X&doi=10.1016/j.jval.2017.08.066
First page :
A409
Section Title :
BREAKOUT SESSION XIII
Open access? :
No
Section Order :
55